This Week on Drug Topics: February 8 to 12
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Coronavirus Research News
With an estimated 42.4 million coronavirus disease 2019 (COVID-19) vaccine doses distributed as of this article’s press time and more than 59 million doses delivered in the United States, keeping up with pandemic news is more important than ever. Check back to Drug Topics® to stay informed on the latest coronavirus-related news and research.
Read more coronavirus-related news.
American Heart Month
February is American Heart Month. Check out our Heart Health section for the latest news and research on cardiovascular-related issues, including COVID-19 effects on heart disease risk.
Medical World News Updates
In part 2 of the interview, Sara Revolinski, PharmD, BCPS, professor Karen Mackinnon, BPharm, RPh, and second-year pharmacy student Celena Ho from the Medical School of Wisconsin Pharmacy School discuss a new program that is training pharmacy students to administer COVID-19 vaccines.
Watch part 1 of the interview.
Drug Topics® interviewed Kaitlyn Rivard, PharmD, infectious diseases clinical pharmacist at the Cleveland Clinic, on her role in getting their COVID-19 vaccination program off the ground. Rivard discusses key insights, advice, and experience in developing an effective COVID-19 vaccination program.
Drug Topics® Journal, February 2021 Digital Edition
The February 2021 digital edition of Drug Topics Journal is now available on DrugTopics.com. In this issue, pharmacists share tips for engaging with patients online, and our cover story highlights practicing culturally competent care to fight health disparities.
View the February digital issue.
In Case You Missed It: Johnson & Johnson Submits EUA for COVID-19 Vaccine Candidate
Johnson & Johnson has submitted an emergency use authorization (EUA) to the FDA for its single-dose vaccine candidate for COVID-19.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
